AB1583-PARE QUALITATIVE INTERVIEWS OF SYMPTOMS, IMPACTS AND SELECTED PROMIS SHORT FORMS: A STUDY IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS

Background

Axial spondyloarthritis (axSpA) is characterised by inflammation of the sacroiliac joints and spine. Sleep disturbance, pain and fatigue are reported in the literature to be key symptoms and impacts of axSpA. Three customised Patient-Reported Outcomes Measurement Information System (PROMIS) Short Forms (Sleep Disturbance, Pain Interference and Fatigue), previously developed for use in rheumatoid arthritis, have been proposed for use in patients with axSpA to assess the key concepts.

Objectives

To conduct in-depth qualitative interviews to further understand the patient experience of axSpA and evaluate the content validity of the three PROMIS Short Forms to support their use as endpoints in axSpA clinical trials.

Methods

A non-interventional, cross-sectional qualitative (concept elicitation [CE] and cognitive debriefing [CD]) study was conducted in 28 adult patients with diagnosed axSpA, including radiographic axSpA (r-axSpA), also known as ankylosing spondylitis (AS, n=12), and non-radiographic axSpA (nr-axSpA, n=16). Patients took part in 90-minute telephone interviews. A semi-structured interview guide was used to assist discussions. The CE section used broad, open-ended questions to elicit information about symptoms and impact experienced by patients. The CD section involved a ‘think-aloud’ exercise in which patients read out each instruction, item and response option for the three PROMIS Short Forms and shared their feedback. Patients were also asked detailed questions about the relevance of the items, response options and recall period. Verbatim interview transcripts were subject to thematic and content analysis.

Results

Patients were from the United States (n=20) and Germany (n=8), mean age was 52.8 years, and 57% (n=16) were male; mean time since diagnosis of axSpA was 9.5 years (range 0.3–31.3 years). The CE section identified 12 distinct signs and symptoms that characterised patients’ experience of axSpA: pain, sleep problems, fatigue/tiredness, stiffness, swelling, vision/eye issues, restricted body movements, headache/migraine, spasms, change in posture/stature, balance/coordination problems and numbness. Pain, sleep problems and fatigue/tiredness were all reported to be experienced by ≥90% of patients, occurring simultaneously and exacerbating one another. 78% (n=21/27) of patients reported pain to be the most bothersome symptom, and 88% (n=23/26) described it as the symptom they would most like treatment to improve. Patients reported axSpA to impact their lives across six health-related quality of life (HRQoL) domains: physical functioning (100%), emotional wellbeing (89%), work/volunteering (79%), social functioning (75%), activities of daily living (61%) and cognitive functioning (54%). Impacts were most frequently described as being associated with pain, stiffness and fatigue. The experiences of symptoms and impacts were consistent between the AS and nr-axSpA patients. CD showed all three PROMIS instruments are conceptually comprehensive and well understood by patients with axSpA. No patients reported misunderstanding of instructions and/or items of the sleep disturbance instrument, and only one and four items had a small number of instances of misunderstanding for the fatigue and pain interference instruments, respectively. Across each instrument, all items were relevant to at least half of patients, and almost all patients reported the instruments to be appropriate for measuring their experience of sleep problems, pain and fatigue due to axSpA. Both AS and nr-axSpA patients confirmed the three PROMIS Short Forms to be relevant and appropriate for assessing their disease experience.

Conclusion

Pain, sleep problems and fatigue are pivotal symptoms of axSpA and associated with HRQoL impacts. Interpretability and content validity of the PROMIS customised Short Forms have been confirmed, with each deemed to adequately assess key impacts associated with axSpA, making them suitable for use in clinical trials of patients with axSpA.

Funding: GSK [209770]

Acknowledgements

Medical writing support was provided by Tony Reardon, of of Aura, a division of Spirit Medical Communications Group Limited (Manchester, UK), and was funded by GlaxoSmithKline.

Disclosure of Interests

Amy Findley Grant/research support from: employee of Adelphi Values, who received fees from GlaxoSmithKline for the conduct of this study, Jessica Middlehurst Grant/research support from: employee of Adelphi Values, who received fees from GlaxoSmithKline for the conduct of this study, Chloe Howse Grant/research support from: employee of Adelphi Values, who received fees from GlaxoSmithKline for the conduct of this study, Molly Clifford Grant/research support from: employee of Adelphi Values, who received fees from GlaxoSmithKline for the conduct of this study, William Neill Grant/research support from: employee of Adelphi Values, who received fees from GlaxoSmithKline for the conduct of this study, Sophi Tatlock Grant/research support from: employee of Adelphi Values, who received fees from GlaxoSmithKline for the conduct of this study, Wen-Hung Chen Shareholder of: GlaxoSmithKline, Employee of: GlaxoSmithKline

, Marguerite Bracher Shareholder of: GlaxoSmithKline, Employee of: GlaxoSmithKline, Dharm Patel Shareholder of: GlaxoSmithKline, Employee of: GlaxoSmithKline

Effects of temperature and salinity on nitrogenous excretion by Litopenaeus vannamei juveniles

Excretion rates of ammonia-N, nitrite-N, nitrate-N, and dissolved organic nitrogen (DON) for juvenile Litopenaeus vannamei (3.85+/-0.83 g) were quantified in response to nine different combinations of temperature (24, 28, and 32 degrees C) and salinity (10, 25, and 40 ppt) under laboratory conditions. Results indicated that L. vannamei is ammonotelic, with ammonia-N accounting for 61.9-84.3% of total nitrogen (TN) excretion. There were significant effects of temperature and salinity, but no significant interaction between them, on ammonia-N excretion rate (R(AN)). R(AN) increased with increasing temperature, over the interval 24-32 degrees C. R(AN) was lower at 25 ppt than at 10 and 40 ppt, at all temperatures. DON excretion rate (R(DON)) was not significantly influenced by either temperature or salinity; the overall mean R(DON) was about 5.24 µg-N g -1 h -1. However, the percentages of DON in TN (P(DON)) varied from 15.4 to 36.4% under the various temperature-salinity combinations. P(DON) at 28 and 32 degrees C was significantly lower than at 24 degrees C, and P(DON) at 10 ppt was significantly lower than at 25 and 40 ppt. Only very small amounts of nitrogen were excreted by L. vannamei as nitrite-N and nitrate-N.

Effects of dietary lipid and environmental salinity on growth, body composition, and cold tolerance of juvenile red drum (Sciaenops ocellatus)

Simultaneous, 6-week feeding trials were conducted in which diets containing menhaden, corn, coconut and hydrogenated menhaden oil at 7.0%, plus a diet containing 14% menhaden oil, were fed to triplicate groups of juvenile red drum (Sciaenops ocellatus) at two different salinities (5 and 32%.). Weight gain was significantly (p < 0.05) affected by diet and salinity. Fish fed the diet containing 14% menhaden oil had the greatest weight gain; whereas, fish fed the diet containing coconut oil gained the least weight. Fish in brackish water had significantly greater weight gain than fish in full-strength seawater over the 6-week period, although fish fed coconut and saturated menhaden oil in brackish water had reduced survival. Dietary lipid also significantly affected muscle and liver total lipid, hepatosomatic index (HSI), and intraperitoneal fat (IPF) ratio, as fish fed the diets containing 14% menhaden oil had higher values for all of these body condition indices.After the feeding trial, fish were subjected to a chronic cold tolerance assay. In the chronic trial, where temperature was gradually reduced over a 3-week period, fish fed the diets containing menhaden oil had significantly lower median lethal temperatures (MLT) than those fish fed the diets containing coconut, corn and saturated menhaden oils. No significant effects of cold exposure were observed on muscle and liver total lipid. Cold exposure prompted a modification in lipid metabolism by lowering total saturated fatty acids and raising (n - 3) highly unsaturated fatty acids (HUFA) in the neutral lipid of liver. Fish with the lowest MLT in the chronic assay exhibited signs of conserving (n - 3) HUFA and depleting (n - 6) fatty acids [primarily 18:2 (n - 6)], resulting in higher (n - 3)/(n - 6) ratios in the polar lipid of liver. These data suggest that the lower lethal temperature of juvenile red drum can be reduced through dietary manipulation involving the inclusion of high levels of dietary lipid rich in (n - 3) HUFA.

A comparison of immunoblotting, flow cytometry and ELISA to monitor the binding of anti-lipopolysaccharide monoclonal antibodies

This study was designed to assess the use of flow cytometry to observe the binding, under physiological conditions, of anti-lipopolysaccharide (LPS) monoclonal antibodies (mAbs) to whole bacteria, and to compare this with the more conventional whole cell ELISA and immunoblotting techniques. The bacteria consisted of two clinical isolates of E. coli 018:K1 and 06:K5 and two isogenic mutants of the 018 parent: a non-capsulate (018:K-) and a rough mutant (018rf). Two cross-reactive anti-core mAbs and one 018 0-antigen-specific mAb were used. ELISA and flow cytometry showed that capsule and O-polysaccharide influenced the binding of mAbs to the bacteria, whilst the latter technique demonstrated that sub-populations existed. Immunoblotting showed the two anti-core mAbs to be different, one bound only to core which was not substituted with O-antigen, whilst the other bound both to substituted and unsubstituted core. This comparison for monitoring the binding of anti-LPS mAbs demonstrates the potential use of flow cytometry in bacterial cell surface research, and complements results obtained by ELISA and immunoblotting.

Antigen presentation in patients with recrudescent orofacial herpes simplex virus infections

Recovery from epidermal herpes simplex virus (HSV) infection depends primarily on development of an effective cell-mediated immune response, possibly generated following antigen (Ag) presentation by epidermal cells (EC). The ability of EC to present HSV Ag was investigated in 12 subjects with occasional recrudescent facial HSV infections. All had circulating HSV specific antibodies and cell-mediated immunity to the virus. Peripheral blood mononuclear cell suspensions, depleted of antigen presenting cells (APC) by glass adherence and then enriched for T cells by adsorption on nylon wool columns, did not proliferate in response to HSV Ag. Both EC suspensions, prepared from suction blister roofs, and glass-adherent peripheral blood mononuclear cells (AC) preincubated with ultraviolet-inactivated HSV, reconstituted the T-cell proliferative response to HSV. EC were more efficient than AC at presenting HSV Ag to T cells. Depletion of CD1+ cells from EC suspensions by cell sorting reduced their ability to present HSV Ag and augmentation of CD1+ cell numbers supplemented it. Preincubation of EC or AC with monoclonal antibodies to major histocompatibility complex class II antigens DP, DQ or DR, blocked the lymphoproliferative response to HSV Ag. Evidence was obtained that cells co-ordinately expressing products of the DP, DQ and DR loci are involved in presentation of HSV Ag by both EC and AC.

Natural killer cell activity in patients with abnormalities of the uterine cervix

Peripheral blood lymphocytes from 105 patients with various degrees of cervical dysplasia (normal/mild, moderate and severe) up to carcinoma in situ were assayed for natural killer cell activity against K562 cells and Chang liver cells in vitro. No difference was found between the natural killer cell activities of any of the groups of patients studied. In addition, the K cell activity of the patients' lymphocytes was assayed in an antibody-dependent cellular cytotoxicity assay on Chang liver cells with anti-Chang cell antiserum. No difference was found between patient groups. There was no correlation between the presence of antibodies in the patients' serum to cytomegalovirus measured by anti-complement immunofluorescence and increased natural killer cell activity.

Behavioural thermoregulation and activity patterns in the green sunfish, Lepomis cyanellus

Behavioural thermoregulation and locomotory activity of green sunfish were examined in a temporal temperature-gradient apparatus. Green sunfish actively avoided temperatures exceeding 30.3 degrees C and below 26.5 degrees C and had a median preferred temperature of 28.2 degrees C. Temperature preference did not vary significantly during the diel period even though locomotory activity patterns were markedly crepuscular. Activity was stimulated by the change in illumination levels at dawn and dusk.

Behavioral thermoregulation by fishes: a new experimental approach

Electronic equipment allows fishes, by their spatial movements, to regulate the temperature in experimental tanks. Swimming into warmer water causes the temperature of the entire tank to increase; conversely, swimming into cooler water causes the temperature to decrease. The technique may be adapted for studying simultaneous behavioral regulation of temperature and nonthermal factors.